121 related articles for article (PubMed ID: 27132888)
1. Mechanism and Role of SOX2 Repression in Seminoma: Relevance to Human Germline Specification.
Kushwaha R; Jagadish N; Kustagi M; Mendiratta G; Seandel M; Soni R; Korkola JE; Thodima V; Califano A; Bosl GJ; Chaganti RSK
Stem Cell Reports; 2016 May; 6(5):772-783. PubMed ID: 27132888
[TBL] [Abstract][Full Text] [Related]
2. Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fate.
Jostes SV; Fellermeyer M; Arévalo L; Merges GE; Kristiansen G; Nettersheim D; Schorle H
Int J Cancer; 2020 Mar; 146(6):1592-1605. PubMed ID: 31583686
[TBL] [Abstract][Full Text] [Related]
3. SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fate.
Nettersheim D; Heimsoeth A; Jostes S; Schneider S; Fellermeyer M; Hofmann A; Schorle H
Oncotarget; 2016 Jul; 7(30):47095-47110. PubMed ID: 27283990
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of SOX2 and SOX17 in testicular germ cell tumors.
Nonaka D
Am J Clin Pathol; 2009 May; 131(5):731-6. PubMed ID: 19369635
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a versatile seminoma model indicates cellular plasticity of germ cell tumor cells.
Nettersheim D; Westernströer B; Haas N; Leinhaas A; Brüstle O; Schlatt S; Schorle H
Genes Chromosomes Cancer; 2012 Jul; 51(7):717-26. PubMed ID: 22489004
[TBL] [Abstract][Full Text] [Related]
6. The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression.
Nettersheim D; Gillis A; Biermann K; Looijenga LH; Schorle H
Genes Chromosomes Cancer; 2011 Dec; 50(12):1033-42. PubMed ID: 21987446
[TBL] [Abstract][Full Text] [Related]
7. Expression of embryonic stem cell markers in cultured JKT-1, a cell line derived from a human seminoma.
Bouskine A; Vega A; Nebout M; Benahmed M; Fénichel P
Int J Androl; 2010 Feb; 33(1):54-63. PubMed ID: 19226408
[TBL] [Abstract][Full Text] [Related]
8. The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas.
Nettersheim D; Arndt I; Sharma R; Riesenberg S; Jostes S; Schneider S; Hölzel M; Kristiansen G; Schorle H
Br J Cancer; 2016 Aug; 115(4):454-64. PubMed ID: 27441500
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of a new human extragonadal germ cell line, SEM-1, and its comparison with TCam-2 and JKT-1.
Russell SM; Lechner MG; Mokashi A; Megiel C; Jang JK; Taylor CR; Looijenga LH; French CA; Epstein AL
Urology; 2013 Feb; 81(2):464.e1-9. PubMed ID: 23374840
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of preferentially expressed antigen in melanoma (PRAME) in testicular germ cell tumors - A comparative study with SOX17.
Zhou Y; Rothrock A; Murugan P; Li F; Bu L
Exp Mol Pathol; 2022 Jun; 126():104761. PubMed ID: 35390309
[TBL] [Abstract][Full Text] [Related]
11. Expression of the RNA component of human telomerase in adult testicular germ cell neoplasia.
Delgado R; Rathi A; Albores-Saavedra J; Gazdar AF
Cancer; 1999 Nov; 86(9):1802-11. PubMed ID: 10547554
[TBL] [Abstract][Full Text] [Related]
12. Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors.
De Jong J; Weeda S; Gillis AJ; Oosterhuis JW; Looijenga LH
Oncol Rep; 2007 Jul; 18(1):127-32. PubMed ID: 17549357
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of SOX17 and SOX2 in germ cells and stem cells has biological and clinical implications.
de Jong J; Stoop H; Gillis AJ; van Gurp RJ; van de Geijn GJ; Boer Md; Hersmus R; Saunders PT; Anderson RA; Oosterhuis JW; Looijenga LH
J Pathol; 2008 May; 215(1):21-30. PubMed ID: 18348160
[TBL] [Abstract][Full Text] [Related]
14. [Embryonal germ cells and germ cell tumors].
Biermann K; Heukamp LC; Nettersheim D; Steger K; Zhou H; Franke FE; Guetgemann I; Sonnack V; Brehm R; Berg J; Bastian PJ; Müller SC; Wang-Eckert L; Schorle H; Büttner R
Verh Dtsch Ges Pathol; 2007; 91():39-48. PubMed ID: 18314594
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide expression profiling reveals new insights into pathogenesis and progression of testicular germ cell tumors.
Biermann K; Heukamp LC; Steger K; Zhou H; Franke FE; Sonnack V; Brehm R; Berg J; Bastian PJ; Muller SC; Wang-Eckert L; Buettner R
Cancer Genomics Proteomics; 2007; 4(5):359-67. PubMed ID: 17993720
[TBL] [Abstract][Full Text] [Related]
16. TCam-2 seminoma cell line exhibits characteristic foetal germ cell responses to TGF-beta ligands and retinoic acid.
Young JC; Jaiprakash A; Mithraprabhu S; Itman C; Kitazawa R; Looijenga LH; Loveland KL
Int J Androl; 2011 Aug; 34(4 Pt 2):e204-17. PubMed ID: 21668453
[TBL] [Abstract][Full Text] [Related]
17. High-throughput microRNAome analysis in human germ cell tumours.
Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the SOX2 neural effector gene by PRDM1 promotes human germ cell fate in embryonic stem cells.
Lin IY; Chiu FL; Yeang CH; Chen HF; Chuang CY; Yang SY; Hou PS; Sintupisut N; Ho HN; Kuo HC; Lin KI
Stem Cell Reports; 2014 Feb; 2(2):189-204. PubMed ID: 24527393
[TBL] [Abstract][Full Text] [Related]
19. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
Looijenga LH
J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
[TBL] [Abstract][Full Text] [Related]
20. In vitro transformation of mouse testis cells by oncogene transfection.
Morimoto H; Lee J; Tanaka T; Ishii K; Toyokuni S; Kanatsu-Shinohara M; Shinohara T
Biol Reprod; 2012 May; 86(5):148, 1-11. PubMed ID: 22357549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
